qNMR: An applicable method for the determination of dimethyltryptamine in ayahuasca, a psychoactive plant preparation Read More > June 11, 2010
Composition, Standardization and Chemical Profiling of Banisteriopsis caapi, a Plant for the Treatment of Neurodegenerative Disorders Relevant to Parkinson’s Disease Read More > April 21, 2010
Ayahuasca Beyond the Amazon: the Benefits and Risks of a Spreading Tradition Read More > April 21, 2010
The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case series Read More > March 26, 2010
The persistence of the subjective in neuropsychopharmacology: observations of contemporary hallucinogen research Read More > February 26, 2010
Cannabis and Ecstasy/MDMA: Empirical Measures of Creativity in Recreational Users Read More > December 25, 2009
Ayahuasca–From Dangerous Drug to National Heritage: An Interview with Antonio A. Arantes Read More > December 9, 2009
Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson's disease Read More > October 30, 2009
